2022 annual financial data
Curanex Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was -77.82%.
Operating income was -20,233 USD and net income was -20,233 USD.
Operating cash flow was 3,336 USD.
Get free Curanex Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,000 USD
- Operating income
- -20,233 USD
- Net income
- -20,233 USD
- Operating cash flow
- 3,336 USD